Table 1.
Patient ID | Karyotype | Sex | Age (years) | Height (m) | Weight (kg) | BMI (kg/m2) | Waist circ. | Hip circ. (cm) | WHR | Fat massa (%) | Fat free massa (%) | Systolic blood pressure (mmHg) | Diastolic blood pressure (mmHg) | Liver steatosis (degree) | Primary amenorrhea | Sex steroid therapy | Current GH therapy | Previous GH therapy |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1PWS | del15 | M | 42.4 | 1.51 | 90.8 | 39.9 | 147 | 123 | 1.20 | 38.5 | 61.5 | 120 | 80 | No | – | No | Yes | No |
2PWS | del15 | M | 29.1 | 1.55 | 69.7 | 29.1 | 104 | 103 | 1.01 | 41.8 | 58.2 | 120 | 70 | Yes (1) | – | No | No | No |
3PWS | del15 | M | 42.8 | 1.57 | 76.4 | 30.9 | 103 | 104 | 0.99 | 30.2 | 69.8 | 120 | 80 | No | – | No | Yes | No |
4PWS | del15 | M | 24.8 | 1.44 | 63.2 | 30.4 | 102 | 102 | 1.00 | 44.6 | 55.4 | 120 | 80 | Yes (2) | – | No | No | No |
5PWS | del15 | F | 47.2 | 1.41 | 91.7 | 46.1 | 121 | 124 | 0.98 | 56.6 | 43.4 | 130 | 80 | Yes (1) | No | No | No | No |
6PWS | del15 | F | 30.9 | 1.44 | 80.6 | 39.1 | 106 | 120 | 0.88 | 52.8 | 47.2 | 130 | 80 | No | Yes | Yes | No | No |
7PWS | del15 | F | 22.2 | 1.65 | 89.2 | 32.8 | 112 | 117 | 0.96 | 44.3 | 55.7 | 120 | 80 | No | Yes | Yes | Yes | NO |
8PWS | del15 | F | 35.3 | 1.66 | 92.0 | 33.5 | 106 | 118 | 0.90 | 46.2 | 53.8 | 130 | 80 | Yes (1) | Yes | Yes | No | Yes |
9PWS | del15 | F | 45.9 | 1.43 | 97.0 | 47.4 | 134 | 130 | 1.03 | 56.9 | 43.1 | 120 | 70 | Yes (1) | No | No | No | No |
10PWS | del15 | F | 36.75 | 1.58 | 108 | 43.5 | 105 | 136 | 0.77 | 50.4 | 49.6 | 130 | 80 | No | Yes | Yes | No | Yes |
Mean | 35.7 | 1.5 | 85.9 | 37.3 | 114.0 | 117.7 | 1.0 | 46.2 | 53.8 | 124.0 | 78.0 | |||||||
St. Dev | 8.8 | 0.1 | 13.4 | 6.8 | 15.3 | 11.6 | 0.1 | 8.3 | 8.3 | 5.2 | 4.2 | |||||||
1OB | – | M | 35.1 | 1.75 | 144.0 | 47.0 | 124 | 142 | 0.87 | 40.1 | 59.9 | 130 | 80 | No | – | |||
2OB | – | M | 28.6 | 1.82 | 149.2 | 45.0 | 141 | 138 | 1.02 | 42.0 | 58.0 | 160 | 90 | Yes (2) | – | |||
3OB | – | M | 37.25 | 1.77 | 124.6 | 39.8 | 124 | 133 | 0.93 | 37.8 | 62.2 | 120 | 80 | Yes (1) | – | |||
4OB | – | M | 31.5 | 1.68 | 101.3 | 36.0 | 105 | 114 | 0.92 | 35.8 | 64.2 | 140 | 70 | No | – | |||
5OB | – | F | 29.0 | 1.70 | 110.2 | 38.1 | 114 | 130 | 0.88 | 48.3 | 51.7 | 120 | 80 | Yes (1) | Yesb | |||
6OB | – | F | 35.9 | 1.57 | 128.4 | 52.1 | 126 | 138 | 0.91 | 58.3 | 41.7 | 120 | 70 | No | Nob | |||
7OB | – | F | 38.2 | 1.64 | 122.6 | 45.6 | 127 | 132 | 0.96 | 56.3 | 43.7 | 110 | 80 | Yes (1) | Yesb | |||
8OB | – | F | 44.0 | 1.65 | 88.1 | 32.5 | 109 | 113 | 0.96 | 42.5 | 57.5 | 110 | 80 | No | Nob | |||
9OB | – | F | 39.7 | 1.64 | 124.4 | 46.3 | 123 | 137 | 0.90 | 42.9 | 57.1 | 120 | 70 | No | Nob | |||
10OB | – | F | 24.0 | 1.60 | 103.2 | 40.3 | 104 | 125 | 0.83 | 48.9 | 51.1 | 120 | 80 | Yes (1) | Yesb | |||
Mean | 34.3 | 1.7 | 119.6 | 42.3 | 119.7 | 130.2 | 0.9 | 45.3 | 54.7 | 125.0 | 78.0 | |||||||
St. Dev | 6.0 | 0.1 | 19.1 | 5.9 | 11.6 | 10.0 | 0.1 | 7.5 | 7.5 | 15.1 | 6.3 |
aDetermined by bioelectrical impedance analysis (Human-IM Scan; DS-Medigroup, Milan, Italy). bSex steroid therapy for contraceptive purpose.